incb000928
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2020 (NCT04582539)
Timeline
Indications
Mechanism of action
- Activin receptor type-1INHIBITOR
ACVR1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05090891 | Phase 2 | Dec 20, 2021 | Incyte |
| NCT05099445 | Phase 1 | Nov 15, 2021 | Incyte |
| NCT04455841 | Phase 1/Phase 2 (Phase 2) | Dec 15, 2020 | Incyte |
| NCT04582539 | Phase 1/Phase 2 (Phase 2) | Nov 30, 2020 | Incyte |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Incyte | For profit | 4 | 4 | 2 | 2020 |
1 organizations
Page 1 / 1